| FCCVX | FTCVX | FCCVX / FTCVX | |
| Total Expense Ratio | 1.76 | 1.24 | 142% |
| Annual Report Gross Expense Ratio | 1.76 | 1.24 | 142% |
| Fund Existence | 17 years | 17 years | - |
| Gain YTD | 14.072 | 14.634 | 96% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | 500 | 500 | 100% |
| Net Assets | 2.17B | 2.17B | 100% |
| Annual Yield % from dividends | 2.07 | 2.49 | 83% |
| Returns for 1 year | 8.06 | 8.64 | 93% |
| Returns for 3 years | 30.93 | 33.02 | 94% |
| Returns for 5 years | 5.14 | 8.13 | 63% |
| Returns for 10 years | 47.74 | 55.49 | 86% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FGSAX | 61.94 | 0.07 | +0.11% |
| Federated Hermes MDT Mid Cap Growth A | |||
| VESGX | 47.30 | N/A | N/A |
| Vanguard Global ESG Select Stk Admiral | |||
| RYYCX | 169.75 | N/A | N/A |
| Rydex S&P SmallCap 600 Pure Value C | |||
| IVGAX | 18.68 | -0.02 | -0.11% |
| VY® Invesco Growth and Income A | |||
| BRWBX | 26.63 | -0.30 | -1.11% |
| MFS Blended Research Growth Eq B | |||